Blood Plasma Products Market: By Product Type (Albumin, Fresh Frozen Plasma (FFP), Immunoglobulin, Protease inhibitors, Others), By Application (Hematology, Hemato-oncology, Immunology, Rheumatology, Others), By End User (Hospitals, Clinical research laboratories, Others) and Geography (North America, Latin America, Europe, Middle East and Africa, Asia Pacific)  

Purchase Option

$ 4400
$ 6600
$ 8900

Blood plasma products market is expected to grow at a significant CAGR of 9% from 2023-2029. Blood plasma products are the liquid components of the blood that are extracted using a process called as fractionation. Blood Plasma plays a major role in the osmotic and electrolytic balance which helps in the prevention of the blood related disorders. Blood plasma is the composition of the water along with various components such as glucose, dissolved proteins, electrolytes, hormones and immunoglobulins. The demand for the plasma derived products is growing along with rising patient population. The inadequacy of the alternative treatment is providing opportunity to the vendors. Blood plasma is crucial for keeping the body's blood pressure in check and for maintaining homeostasis. It also delivers multiple hormones and proteins to various sections of the body and aids in blood coagulation and disease prevention. It is mostly water (up to 95 percent by volume) with important dissolved proteins (68%) (e.g., serum albumins, globulins, and fibrinogen), glucose, clotting factors, electrolytes (Na+, Ca2+, Mg2+, HCO3, Cl, etc.), hormones, carbon dioxide (plasma being the main medium for excretory product transportation), and oxygen. Blood plasma's benefits, such as clotting, defence, nutrition, managing acid-base balance, maintaining osmotic pressure, respiration, excretion, and controlling body temperature, are also expected to drive market expansion. Moreover, the market is expected to be fueled by an increase in plasma collection facilities, developments in this area, and acceptance of blood plasma-derived products throughout the estimated period.

Blood Plasma Products Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

9%

Largest Market

North America

Fastest Growing Market

Europe
Dynamics

Increase in the prevalence of blood disorders is the major factor anticipating to drive the growth of the market. According to the World Federation of Hemophilia, the number of people suffering from blood disorders are 304,362. The government initiatives and support from the non-profitable organizations adding the growth of the market. The awareness programs conducted by various government and private organizations to support the blood donation, which would meet the growing demand of the plasma is enhancing the growth of the market. The age related issues in the ageing population is also likely to enrich the growth of the market over the forecast period. However, the high cost involved in the treatment is likely to hinder the growth of the market. The stringent regulation on the import and export of the plasma products is also expected to hamper the growth of the market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Blood Plasma Products Market Segmentation

By Product Type
  • Albumin
  • Fresh Frozen Plasma (FFP)
  • Immunoglobulin
  • Protease inhibitors
  • Others
By Application
  • Hematology
  • Hemato-oncology
  • Immunology
  • Rheumatology
  • Others
By End User
  • Hospitals
  • Clinical Research Laboratories
  • Others
By Geography
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East Africa

Frequently Asked Questions

The key segments covered in the Blood Plasma Products Market are technology, components, application, and end-users.

The Blood Plasma Products Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

The Blood Plasma Products Market key players are China Biologic Products (China), Grifols (Spain), Shire (Ireland), Kedrion (Italy), Octapharma (Switzerland), Shanghai RAAS, Blood Products (China), CSL (Australia), Bio Product Laboratory (UK)

  1. Executive Summary
  2. Global Blood Plasma Products Market Introduction
    • Global Blood Plasma Products Market Taxonomy
    • Global Blood Plasma Products Market Definitions
      • Product Type
      • Application
      • End User
  3. Global Blood Plasma Products Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Blood Plasma Products Market Dynamic Factors - Impact Analysis
    • Global Blood Plasma Products Market Competition Landscape
    • Epidemiology
  4. Global Blood Plasma Products Market Analysis, 2018-2022 and Forecast, 2023-2029
    • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  5. Global Blood Plasma Products Market, By Product Type, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
    • Albumin
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Fresh Frozen Plasma (FFP)
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Immunoglobulin
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Protease inhibitors
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis

         6. Global Blood Plasma Products Market Forecast, By Application,2018-2022 and Forecast, 2023-2029

    • Hematology
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Hemato-oncology
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Immunology
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Rheumatology
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis

       7. Global Blood Plasma Products Market Forecast, By End User, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

    • Hospitals
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Clinical Research Laboratories
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis

        8. Global Blood Plasma Products Market Forecast, By Region, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

    • North America
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Blood Plasma Products Market - Opportunity Analysis Index, By Product Type, By Application, By End User, and Region, 2020 2026

        9. North America Blood Plasma Products Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

    • Product Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Albumin
      • Fresh Frozen Plasma (FFP)
      • Immunoglobulin
      • Protease inhibitors
      • Others
    • Application Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hematology
      • Hemato-oncology
      • Immunology
      • Rheumatology
      • Others
    • End User Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinical Research Laboratories
      • Others
    • Country Analysis 2016 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • S.
      • Canada
    • North America Blood Plasma Products Market - Opportunity Analysis Index, By Product Type, By Application, By End User, and Country, 2023-2029
    • North America Blood Plasma Products Market Dynamics Trends

      10. Europe Blood Plasma Products Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

    • Product Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Albumin
      • Fresh Frozen Plasma (FFP)
      • Immunoglobulin
      • Protease inhibitors
      • Others
    • Application Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hematology
      • Hemato-oncology
      • Immunology
      • Rheumatology
      • Others
    • End User Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinical Research Laboratories
      • Others
    • Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Blood Plasma Products Market - Opportunity Analysis Index, By Product Type, By Application, By End User, and Country, 2023-2029
    • Europe Blood Plasma Products Market Dynamics Trends

11. Asia-Pacific Blood Plasma Products Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

    • Product Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Albumin
      • Fresh Frozen Plasma (FFP)
      • Immunoglobulin
      • Protease inhibitors
      • Others
    • Application Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hematology
      • Hemato-oncology
      • Immunology
      • Rheumatology
      • Others
    • End User Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinical Research Laboratories
      • Others
    • Country Analysis2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Blood Plasma Products Market - Opportunity Analysis Index, By Product Type, By Application, By End User, and Country, 2023-2029
    • Asia-Pacific Blood Plasma Products Market Dynamics Trends

12. Latin America Blood Plasma Products Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

    • Product Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Albumin
      • Fresh Frozen Plasma (FFP)
      • Immunoglobulin
      • Protease inhibitors
      • Others
    • Application Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hematology
      • Hemato-oncology
      • Immunology
      • Rheumatology
      • Others
    • End User Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinical Research Laboratories
      • Others
    • Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Blood Plasma Products Market - Opportunity Analysis Index, By Product Type, By Application, By End User, and Country, 2023-2029
    • Latin America Blood Plasma Products Market Dynamics Trends

      13. Middle East and Africa Blood Plasma Products Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn)

    • Product Type Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Albumin
      • Fresh Frozen Plasma (FFP)
      • Immunoglobulin
      • Protease inhibitors
      • Others
    • Application Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hematology
      • Hemato-oncology
      • Immunology
      • Rheumatology
      • Others
    • End User Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinical Research Laboratories
      • Others
    • Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Blood Plasma Products Market - Opportunity Analysis Index, By Product Type, By Application, By End User, and Country, 2023-2029
    • MEA Blood Plasma Products Market Dynamics Trends

     14. Competition Landscape

    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Product Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • China Biologic Products (China)
      • Grifols (Spain)
      • Shire (Ireland)
      • Kedrion (Italy)
      • Octapharma (Switzerland)
      • Shanghai RAAS Blood Products (China)
      • CSL (Australia)
      • Bio Product Laboratory (UK)

    15. Research Methodology

    16. Key Assumptions and Acronyms

 

  • China Biologic Products (China)
  • Grifols (Spain)
  • Shire (Ireland)
  • Kedrion (Italy)
  • Octapharma (Switzerland)
  • Shanghai RAAS Blood Products (China)
  • CSL (Australia)
  • Bio Product Laboratory (UK)

Adjacent Markets